Stage IV Breast Cancer: Nina's Survivor Story

Patient Info: Nina, Female, Under 40 | Stage IV

Metastatic Site: Spine

As of November 2024, Nina had Stage IV metastatic breast cancer with prior spine metastasis, remained on indefinite infusions and medications, and had current scans showing no evidence of disease.

The Patient StoryRead more →

Rare squamous cell breast cancer: tumorectomy and partial mastectomy

Patient Info: Anonymized, Female, 40s | Stage I

Biomarkers: ER-negative; PR-negative; HER2-negative; Ki-67 21%, triple negative

As of August 2024, she had no recurrence 4 years after surgery, adjuvant AC/docetaxel chemotherapy, and residual breast irradiation for Stage I squamous cell carcinoma of the breast arising in a benign phyllodes tumor.

PubMed CentralRead more →

Stage IIIA HR-positive HER2-negative breast cancer with radiation-induced brachial plexopathy

Patient Info: Anonymized, Female, 50s | Stage I

Biomarkers: HR-positive/HER2-negative breast cancer with pathogenic ATM and PALB2 variants plus an ATM VUS.

Approximately 3.5 years after radiation therapy, there was no evidence of breast cancer recurrence, but severe radiation-induced brachial plexopathy, fibrosis, telangiectasias, and lymphedema-related symptoms required ongoing supportive care.

PubMed CentralRead more →

Stage IV HER2-Positive Breast Cancer: Nina's Survivor Story

Patient Info: Nina, Female, Under 40 | Stage IV

Biomarkers: HER2-positive; broad hereditary genetic testing negative

Metastatic Site: spine

As of November 2024, Nina described being in a no-evidence-of-disease phase, while continuing treatment because of her Stage IV HER2-positive metastatic breast cancer history.

The Patient StoryRead more →

Triple-Negative Breast Cancer in a Young Woman With Bloom Syndrome Followed by Myelodysplastic Syndrome

Patient Info: Anonymized, Female, Under 40

Biomarkers: Triple-negative

Follow-up imaging after breast-cancer treatment showed no malignant lesions. Eight months after treatment, she developed myelodysplastic syndrome with excess blasts and later died from sepsis at age 33.

PubMed CentralRead more →

Breast invasive lobular carcinoma metastatic to the endometrium: hysterectomy and hormone therapy

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: HER2 negative, PR/HER2 negative.

Metastatic Site: endometrium (endometrial polyp)

No signs of recurrence were reported 18 months after total hysterectomy with bilateral adnexectomy for endometrial metastasis from invasive lobular breast carcinoma, with scheduled follow-up every 3 to 6 months.

PubMed CentralRead more →

Stage II Invasive Ductal Carcinoma: Lauren's Survivor Story

Patient Info: Lauren, Female | Stage II

As of November 2024, Lauren had completed surgery, chemotherapy, and 25 rounds of radiation for Stage II invasive ductal breast cancer and was moving into survivorship.

The Patient StoryRead more →

Hormone receptor-positive breast cancer metastatic to the pituitary: surgery and disease-free follow-up

Patient Info: Anonymized, Female, 40s | Stage IV

Biomarkers: ER 2+; PR 1+; HER2 0; GATA3 positive; CA125 elevated

Metastatic Site: pituitary

Disease-free 11 months after surgical resection of pituitary metastasis from prior hormone receptor-positive, HER2-negative breast cancer, with postoperative recovery supported by antibiotics, hormone replacement/supportive therapy, and electrolyte management.

PubMed CentralRead more →

HR-Positive Breast Cancer: Anna's Survivor Story

Patient Info: Anna, Female, Under 40

Biomarkers: ER-positive; PR-positive; HER2-positive

As of October 2024, Anna was about 7 years from diagnosis and described long-term survivorship after surgery, chemotherapy, radiation, biologic treatment, and tamoxifen-related mental-health effects.

The Patient StoryRead more →

Anna’s Triple-Positive Breast Cancer Story

Patient Info: Anna, Female, Under 40

Biomarkers: ER-positive, PR-positive and HER2-positive

Anna completed surgery, chemotherapy and radiation and continued to navigate the effects of hormone therapy, early menopause and fertility loss.

The Patient StoryRead more →

Stage II Triple-Negative Breast Cancer: Italia's Survivor Story

Patient Info: Italia Russell, Female, Under 40 | Stage II

Biomarkers: ER-negative; PR-negative; HER2-negative; BRCA mutation

As of October 2024, Italia had no evidence of disease after Stage II triple-negative breast cancer responded to chemotherapy, the tumor was gone by double mastectomy, and she was completing immunotherapy with 3 infusions left.

Cleveland ClinicRead more →

Breast Cancer: Francina's Survivor Story

Patient Info: Francina, Female

Biomarkers: Biomarker testing performed; specific markers not reported

As of October 2024, Francina described herself as 6.5 years cancer-free after surgery, chemotherapy, radiation, and biomarker-guided treatment planning.

The Patient StoryRead more →

Triple-negative breast cancer in remission after chemotherapy and pembrolizumab

Patient Info: Anonymized, Female, 50s

Biomarkers: ER-negative; PR-negative; HER2-negative

Triple-negative breast cancer was in remission, with PET-CT showing no new primary or secondary tumors, while pembrolizumab-related adrenal insufficiency required ongoing endocrine management.

PubMed CentralRead more →

Triple-Negative Breast Cancer: Erica's Survivor Story

Patient Info: Erica Watson, Female, 50s

Biomarkers: ER-negative; PR-negative; HER2-negative

As of October 2024, Erica had no evidence of disease after triple-negative breast cancer showed a complete response to 16 chemotherapy treatments, lumpectomy, reconstructive surgery and 15 rounds of radiation.

Cleveland ClinicRead more →

Stage IV HR-Positive Invasive Ductal Carcinoma: Dee's Patient Story

Patient Info: Dee, Female, Under 40 | Stage IV

Biomarkers: ER-positive

Metastatic Site: Bones

As of October 2024, Dee was living with Stage IV metastatic ER-positive breast cancer after bone metastases were found in 2023 and had adapted to treatment with ribociclib.

The Patient StoryRead more →

Breast Cancer: Cécilia's Patient Story

Patient Info: Cécilia, Female

As of October 2024, Cécilia described breast cancer diagnosed during the 7th month of pregnancy, intravenous chemotherapy during pregnancy, and delivery planned between chemotherapy cycles; final disease status was not reported.

YouTube (FR search)Read more →

Starting Chemotherapy After Breast Cancer Surgery With an Unexpected Vein Anomaly

Patient Info: Anonymized, Female, 50s

She completed her first adjuvant chemotherapy session without significant discomfort after the infusion port was repositioned for a persistent left superior vena cava.

PubMed CentralRead more →

Invasive Ductal Carcinoma: Lauren's Survivor Story

Patient Info: Lauren O'Connell, Female

As of September 2024, Lauren had completed lumpectomy, chemotherapy, and 25 rounds of radiation. She described major emotional change and recovery, but no formal NED or cancer-free status was reported.

YouTube — The Patient StoryRead more →

Stage IV HER2-Positive Invasive Ductal Carcinoma: Dee's Patient Story

Patient Info: Dee Doherty, Female, Under 40 | Stage IV

Biomarkers: Hormone-sensitive disease implied by letrozole and ovarian suppression; ER/PR/HER2 status not explicitly stated

Metastatic Site: bone

As of September 2024, Dee was living with Stage IV metastatic breast cancer. Her tumors had not shrunk, but disease was stable on ribociclib/Kisqali, letrozole, and ovarian suppression.

The Patient StoryRead more →

Stage III HER2-Positive Occult Breast Cancer With a Complete Response to Treatment

Patient Info: Anonymized, Female, 40s | Stage III

Biomarkers: HER2-positive

Surgery after neoadjuvant treatment found no residual tumor in the breast or 20 examined lymph nodes, indicating a complete pathologic response; HER2-targeted therapy continued afterward.

PubMed CentralRead more →

Stage II HER2-Positive Breast Cancer With Fever and a Reversible Brain MRI Lesion After Radiotherapy

Patient Info: Anonymized, Female, Under 40 | Stage II

Biomarkers: ER-positive, PR-positive, HER2-positive

After radiotherapy, fever, neutropenia, headache, and a reversible splenial brain lesion resolved with supportive and antibiotic treatment during her postoperative breast-cancer treatment course.

PubMed CentralRead more →

Stage IV KRAS Breast Cancer: Lauren's Patient Story

Patient Info: Lauren, Female | Stage IV

Biomarkers: KRAS mutation in colon cancer context

Metastatic Site: Abdominal lining; spine

As of September 2024, Lauren was living with a history of Stage IV colon cancer and recurrent metastatic breast cancer in the spine, with low colon tumor markers, recurring spinal spots, and PET scans every 3 months.

The Patient StoryRead more →

Stage 4 breast cancer: complete remission with letrozole and palbociclib

Patient Info: Anonymized, Female | Stage IV

Biomarkers: Breast cancer was ER/PR positive, HER2 0

Metastatic Site: pleura/pleural effusion

Breast cancer remained in remission on letrozole after palbociclib was stopped; Ph-positive B-ALL achieved complete response with no molecular residual disease after blinatumomab plus ponatinib, with ongoing monthly outpatient monitoring.

PubMed CentralRead more →

Hormone receptor-positive invasive lobular carcinoma treated with neoadjuvant chemotherapy

Patient Info: Anonymized, Female, 50s | Stage II

Biomarkers: ER-positive; PR-positive; HER2-negative; Ki-67 20%

Three-month follow-up showed the biopsy-related pseudoaneurysm had thrombosed and regressed, clearing the way for planned neoadjuvant chemotherapy and surgery; cancer response after planned treatment was not yet available.

PubMed CentralRead more →